
The global PCR Solution market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029.
Key companies engaged in the PCR Solution industry include Lepu Medical Technology, QIAGEN, Agilent, Analytik Jena, Autogen Inc, Bioer, Bio-Rad, Biosynex and ELITech Group, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of PCR Solution were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole PCR Solution market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global PCR Solution market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Lepu Medical Technology
QIAGEN
Agilent
Analytik Jena
Autogen Inc
Bioer
Bio-Rad
Biosynex
ELITech Group
Esco
Hamilton Robotics
Promega
Roche
Texas BioGene
Thermo Fisher
Segment by Type
Nucleic Acid Extractor
Real-time PCR System
Nucleic Acid Test Kit
Disposable Sample Collection Kit
Others
Segment by Application
Hospital
Laboratory
Forensic Institutions
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The PCR Solution report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global PCR Solution Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Nucleic Acid Extractor
1.2.3 Real-time PCR System
1.2.4 Nucleic Acid Test Kit
1.2.5 Disposable Sample Collection Kit
1.2.6 Others
1.3 Market by Application
1.3.1 Global PCR Solution Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Laboratory
1.3.4 Forensic Institutions
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global PCR Solution Market Perspective (2018-2029)
2.2 PCR Solution Growth Trends by Region
2.2.1 Global PCR Solution Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 PCR Solution Historic Market Size by Region (2018-2023)
2.2.3 PCR Solution Forecasted Market Size by Region (2024-2029)
2.3 PCR Solution Market Dynamics
2.3.1 PCR Solution Industry Trends
2.3.2 PCR Solution Market Drivers
2.3.3 PCR Solution Market Challenges
2.3.4 PCR Solution Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top PCR Solution Players by Revenue
3.1.1 Global Top PCR Solution Players by Revenue (2018-2023)
3.1.2 Global PCR Solution Revenue Market Share by Players (2018-2023)
3.2 Global PCR Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by PCR Solution Revenue
3.4 Global PCR Solution Market Concentration Ratio
3.4.1 Global PCR Solution Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by PCR Solution Revenue in 2022
3.5 PCR Solution Key Players Head office and Area Served
3.6 Key Players PCR Solution Product Solution and Service
3.7 Date of Enter into PCR Solution Market
3.8 Mergers & Acquisitions, Expansion Plans
4 PCR Solution Breakdown Data by Type
4.1 Global PCR Solution Historic Market Size by Type (2018-2023)
4.2 Global PCR Solution Forecasted Market Size by Type (2024-2029)
5 PCR Solution Breakdown Data by Application
5.1 Global PCR Solution Historic Market Size by Application (2018-2023)
5.2 Global PCR Solution Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America PCR Solution Market Size (2018-2029)
6.2 North America PCR Solution Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America PCR Solution Market Size by Country (2018-2023)
6.4 North America PCR Solution Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe PCR Solution Market Size (2018-2029)
7.2 Europe PCR Solution Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe PCR Solution Market Size by Country (2018-2023)
7.4 Europe PCR Solution Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific PCR Solution Market Size (2018-2029)
8.2 Asia-Pacific PCR Solution Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific PCR Solution Market Size by Region (2018-2023)
8.4 Asia-Pacific PCR Solution Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America PCR Solution Market Size (2018-2029)
9.2 Latin America PCR Solution Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America PCR Solution Market Size by Country (2018-2023)
9.4 Latin America PCR Solution Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa PCR Solution Market Size (2018-2029)
10.2 Middle East & Africa PCR Solution Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa PCR Solution Market Size by Country (2018-2023)
10.4 Middle East & Africa PCR Solution Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lepu Medical Technology
11.1.1 Lepu Medical Technology Company Detail
11.1.2 Lepu Medical Technology Business Overview
11.1.3 Lepu Medical Technology PCR Solution Introduction
11.1.4 Lepu Medical Technology Revenue in PCR Solution Business (2018-2023)
11.1.5 Lepu Medical Technology Recent Development
11.2 QIAGEN
11.2.1 QIAGEN Company Detail
11.2.2 QIAGEN Business Overview
11.2.3 QIAGEN PCR Solution Introduction
11.2.4 QIAGEN Revenue in PCR Solution Business (2018-2023)
11.2.5 QIAGEN Recent Development
11.3 Agilent
11.3.1 Agilent Company Detail
11.3.2 Agilent Business Overview
11.3.3 Agilent PCR Solution Introduction
11.3.4 Agilent Revenue in PCR Solution Business (2018-2023)
11.3.5 Agilent Recent Development
11.4 Analytik Jena
11.4.1 Analytik Jena Company Detail
11.4.2 Analytik Jena Business Overview
11.4.3 Analytik Jena PCR Solution Introduction
11.4.4 Analytik Jena Revenue in PCR Solution Business (2018-2023)
11.4.5 Analytik Jena Recent Development
11.5 Autogen Inc
11.5.1 Autogen Inc Company Detail
11.5.2 Autogen Inc Business Overview
11.5.3 Autogen Inc PCR Solution Introduction
11.5.4 Autogen Inc Revenue in PCR Solution Business (2018-2023)
11.5.5 Autogen Inc Recent Development
11.6 Bioer
11.6.1 Bioer Company Detail
11.6.2 Bioer Business Overview
11.6.3 Bioer PCR Solution Introduction
11.6.4 Bioer Revenue in PCR Solution Business (2018-2023)
11.6.5 Bioer Recent Development
11.7 Bio-Rad
11.7.1 Bio-Rad Company Detail
11.7.2 Bio-Rad Business Overview
11.7.3 Bio-Rad PCR Solution Introduction
11.7.4 Bio-Rad Revenue in PCR Solution Business (2018-2023)
11.7.5 Bio-Rad Recent Development
11.8 Biosynex
11.8.1 Biosynex Company Detail
11.8.2 Biosynex Business Overview
11.8.3 Biosynex PCR Solution Introduction
11.8.4 Biosynex Revenue in PCR Solution Business (2018-2023)
11.8.5 Biosynex Recent Development
11.9 ELITech Group
11.9.1 ELITech Group Company Detail
11.9.2 ELITech Group Business Overview
11.9.3 ELITech Group PCR Solution Introduction
11.9.4 ELITech Group Revenue in PCR Solution Business (2018-2023)
11.9.5 ELITech Group Recent Development
11.10 Esco
11.10.1 Esco Company Detail
11.10.2 Esco Business Overview
11.10.3 Esco PCR Solution Introduction
11.10.4 Esco Revenue in PCR Solution Business (2018-2023)
11.10.5 Esco Recent Development
11.11 Hamilton Robotics
11.11.1 Hamilton Robotics Company Detail
11.11.2 Hamilton Robotics Business Overview
11.11.3 Hamilton Robotics PCR Solution Introduction
11.11.4 Hamilton Robotics Revenue in PCR Solution Business (2018-2023)
11.11.5 Hamilton Robotics Recent Development
11.12 Promega
11.12.1 Promega Company Detail
11.12.2 Promega Business Overview
11.12.3 Promega PCR Solution Introduction
11.12.4 Promega Revenue in PCR Solution Business (2018-2023)
11.12.5 Promega Recent Development
11.13 Roche
11.13.1 Roche Company Detail
11.13.2 Roche Business Overview
11.13.3 Roche PCR Solution Introduction
11.13.4 Roche Revenue in PCR Solution Business (2018-2023)
11.13.5 Roche Recent Development
11.14 Texas BioGene
11.14.1 Texas BioGene Company Detail
11.14.2 Texas BioGene Business Overview
11.14.3 Texas BioGene PCR Solution Introduction
11.14.4 Texas BioGene Revenue in PCR Solution Business (2018-2023)
11.14.5 Texas BioGene Recent Development
11.15 Thermo Fisher
11.15.1 Thermo Fisher Company Detail
11.15.2 Thermo Fisher Business Overview
11.15.3 Thermo Fisher PCR Solution Introduction
11.15.4 Thermo Fisher Revenue in PCR Solution Business (2018-2023)
11.15.5 Thermo Fisher Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Lepu Medical Technology
QIAGEN
Agilent
Analytik Jena
Autogen Inc
Bioer
Bio-Rad
Biosynex
ELITech Group
Esco
Hamilton Robotics
Promega
Roche
Texas BioGene
Thermo Fisher
Ěý
Ěý
*If Applicable.
